Stock DGX QUEST DIAGNOSTICS INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

News Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Real-time Estimate Cboe BZX
Other stock markets
 12:46:42 2024-04-23 pm EDT 		5-day change 1st Jan Change
135.7 USD +4.33% Intraday chart for Quest Diagnostics Incorporated +6.46% -1.62%
03:05pm Sector Update: Health Care Stocks Steady Pre-Bell Tuesday MT
02:30pm Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday
MT
Transcript : Quest Diagnostics Incorporated, Q1 2024 Earnings Call, Apr 23, 2024
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised
MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q1 Revenue $2.37B, vs. Street Est of $2.29B
MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q1 EPS $2.04, vs. Street Est of $1.86
MT
Quest Diagnostics: Q1 Earnings Snapshot
AQ
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024
PR
Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024
CI
MORNING BID AMERICAS-Tanking Tesla reports, Europe business beats
RE
Quest Diagnostics Launches New Test to Help Assess Alzheimer's Disease Risk
MT
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
PR
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease
CI
John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission
CI
Quest Diagnostics Receives Shareholder Proposal from John Chevedden
CI
Ex-dividend day
FA
Quest Diagnostics and Broad Clinical Labs to Evaluate Whole Genome Sequencing as First-Line Genetic Test for Developmental Delay
AQ
Quest Collaborating With Broad Clinical Labs to Assess Whole Genome Sequencing Test for Developmental Delay Disorders
MT
Quest Diagnostics - Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's disease
AQ
Study in Frontiers in Neurology Affirms Amyloid Blood Test Can Help Identify Patients Who May Forgo Imaging Evaluation for Alzheimer's Disease
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DGX Stock
  4. News Quest Diagnostics Incorporated